A Practical Approach to Minimize the Burden of CKD-Induced Anemia

On-Demand Slide Lecture with Audio

Sponsored by North American Center for Continuing Medical Education, LLC

Faculty

Presenter/Q&A Cohost

Jay B. Wish, MD
Medical Director, Dialysis Program
University Hospitals Case Medical Center
Professor of Medicine
Case Western Reserve University
Cleveland, Ohio

Q&A Cohost

Ann Compton, MSN, FNP-C, CNN
Family Nurse Practitioner
Division of Nephrology
Virginia Commonwealth University Health Systems
Richmond, Virginia

Target Audience

This activity is designed for nurses, nurse practitioners, and physician assistants.

Learning Objectives

After completing this activity, participants should be able to:

• Facilitate proper risk stratification, screening, and early management of chronic kidney disease (CKD)-induced anemia
• Implement evidence-based techniques for ongoing monitoring of patients with CKD-induced anemia to optimize the effectiveness of therapy
• Outline special treatment considerations for older patients with CKD-induced anemia
• Integrate current guidelines into daily practice when diagnosing and managing CKD-induced anemia to maximize daily functioning, quality of life, and health outcomes

Activity Overview

This on-demand slide lecture is available with html slides and the presentation transcript.

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this activity.

Release Date: July 10, 2009

Expiration Date: July 10, 2010

Estimated time to complete: 1 hour

For questions regarding this educational activity, please contact Angela Scarnici at 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation (Accepted for Physician Assistants)

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

CNE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1.0 contact hour(s). Provider #: 110-3-E-06.

Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1.0 contact hours.

AANP Accreditation

This program is approved for 1 contact hour(s) of continuing education by the American Academy of Nurse Practitioners. Program ID 0903127.

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

ANNA Accreditation

This continuing nursing education activity was approved by the American Nephrology Nurses’ Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Independent Clinical Reviewer: Lynda Anne Szczech, MD, MSCE, Associate Professor, Division of Nephrology, Duke University Medical Center, Durham, North Carolina

Nurse Reviewer: Ann Compton, MSN, FNP-C, CNN, Family Nurse Practitioner, Division of Nephrology, Medical College of Virginia, Richmond, Virginia

Planning Committee

The planning committee comprises Ann Compton, MSN, FNP-C, CNN, Carla Moschella, PA-C, MS, RD, Lynda Anne Szczech, MD, MSCE, Jay B. Wish, MD; Kristin Dickie, Mary Johnson, Mike Kearney, Nick Lombardi, Erin Phelps, Randy Robbin, John Savage, and Jessica Steuerman, NACCME.

Financial Disclosure and Conflicts of Interest  

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
                
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Ms. Compton: Speakers bureau—Amgen, Genzyme Corporation, Watson Pharmaceuticals
Dr. Szczech: Consultant—Affymax, Inc, Fresenius Medical Care North America; Speakers bureau—AMAG Pharmaceutical, Inc
Dr. Wish: Scientific advisor—AMAG Pharmaceutical, Inc, Amgen, Centocor Ortho Biotech, Watson Pharmaceuticals; Speakers bureau—AMAG Pharmaceutical, Inc, Watson Pharmaceuticals
Ms. Moschella disclosed no relevant financial relationships with any commercial interests.

Ms. Dickie, Ms. Johnson, Mr. Kearney, Mr. Lombardi, Ms. Phelps, Mr. Robbin, Mr. Savage, and Ms. Steuerman have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed the following off-label/unapproved use(s) of drugs and/or devices will be discussed: Extended dosing with erythropoiesis-stimulating agents for the treatment of CKD-induced anemia.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2009 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Centocor Ortho Biotech